| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.27 | 9e-07 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.23 | 5e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 6e-05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.24 | 0.0001 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |